News

Mar 16th, 2020

Mifepristone pretreatment followed by misoprostol 200mcg buccal for the medical management of intrauterine fetal death at 14-28 weeks: A randomized, placebo-controlled, double blind trial

Mar 10th, 2020

High fever after sublingual administration of misoprostol for treatment of post-partum haemorrhage: a hospital-based, prospective observational study in Argentina

Feb 20th, 2020

TelAbortion Webinar March 11 2020, 3-4pm EST

Feb 4th, 2020

Newsletter February 2020

Dec 9th, 2019

Gynuity - RHSC Webinar December 12

Oct 2nd, 2019

Mifepristone's multiple reproductive health indications

Sep 26th, 2019

Newsletter September 2019

Sep 25th, 2019

Medical abortion telemedicine pilot launched in Mexico

Sep 19th, 2019

The effectiveness and safety of introducing condom-catheter uterine balloon tamponade for postpartum haemorrhage

Sep 17th, 2019

The correlation of postpartum blood loss and poor clinical outcomes

Mar 8th, 2019

Newsletter March 2019

Mar 6th, 2019

Gynuity's TelAbortion project featured in The New Yorker

Dec 14th, 2018

Newsletter December 2018

Oct 23rd, 2018

CNN coverage of Gynuity's Telabortion study

Oct 3rd, 2018

Webinar, October 3 – IPPF’s new medical abortion commodities database

Sep 28th, 2018

Newsletter September 2018

Jul 19th, 2018

The Atlantic features Gynuity research in an article about online abortion pills in the US

May 22nd, 2018

Newsletter May 2018

Apr 25th, 2018

Gizmodo report features the TelAbortion study

Mar 8th, 2018

Gynuity staff present on postpartum hemorrhage diagnosis & management at upcoming EBCOG Congress

Mar 1st, 2018

TelAbortion study featured in Cosmopolitan

Jan 19th, 2018

Telabortion project referenced in Chicago Tribune

Jan 3rd, 2018

Telemedicine abortion study featured on local Hawaii news station

Dec 21st, 2017

Newsletter December 2017

Dec 5th, 2017

No Magic Bullets: Translating Evidence into Effective PPH Programs